Eldorado Gold Announces Strong 2021 Preliminary Production of 475,912 oz; Announces Board and Management Appointments; and Provides Conference Call Details

NEXT STORY
Leda Health Wins CES 2022 Innovation Award for Early Evidence Kit and Platform
PREV STORY
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in November 

REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News

Cytokinetics Completes Enrollment in VITALITY-ALS, Phase 3 Clinical Trial of Tirasemtiv in Patients With ALS

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) today ...

author_avatar
NASDAQ Market News

Dynavax Reports Fourth Quarter and Year End 2017 Financial Results

HEPLISAV-B Launched in the United States Phase 2 Data in Two Immuno-oncology Programs Planned ...

author_avatar
NASDAQ Market News